Skip to main content
Premium Trial:

Request an Annual Quote

Univ. of Amsterdam, GeneGo Team on Metabolic Diseases Project

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Amsterdam will work with GeneGo through the company's MetaMiner Metabolic Diseases project, GeneGo said today.

The MetaMiner program is aimed at studying human diseases by using 'omics data to study disease pathways and gene-disease associations, the company said.

Through the multi-year MetaMiner programs, GeneGo develops content and tools while members, such as the University of Amsterdam or pharmaceutical companies, direct the process, prioritize goals, and edit the disease pathways. Current MetaMiner projects include collaborations in oncology, cystic fibrosis, cardiovascular diseases, and stem cells.

Milka Sokolovic at the Academic Medical Center at the University of Amsterdam said in a statement that GeneGo's disease pathway reconstructions are "fundamentally important and required for the understanding of disease processes so we can find cures."

"This will be the first 'systems analysis' platform devoted specifically for metabolic diseases," GeneGo VP of Business Development Julie Bryant said in a statement. "We will start with the 'usual suspects' of type 2 diabetes and obesity and then move to other human diseases which significantly affect metabolism."

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.